OnabotulinumtoxinA affects cortical recovery period but not occurrence or propagation of cortical spreading depression in rats with compromised blood

OnabotulinumtoxinA affects cortical recovery period but not occurrence or propagation of cortical spreading depression in rats with compromised blood–brain barrier

Published:2021-03-16 Issue:9 Volume:162 Page:2418-2427
ISSN:0304-3959
Container-title:Pain
language:en
Short-container-title:PAIN

Author:

Melo-Carrillo Agustin,Strassman Andrew M.,Schain Aaron J.,Broide Ron S.,Cai Brian B.,Rhéaume Catherine,Brideau-Andersen Amy D.,Ashina Sait,Flores-Montanez Yadira,Brin Mitchell F.,Burstein Rami

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Anesthesiology and Pain Medicine,Neurology (clinical),Neurology

Reference53 articles.

1. Safety and efficacy of repeated injections of botulinum toxin A in peripheral neuropathic pain (BOTNEP): a randomised, double-blind, placebo-controlled trial;Attal;Lancet Neurol,2016

2. OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial;Aurora;Cephalalgia,2010

3. Suppression of cortical spreading depression in migraine prophylaxis;Ayata;Ann Neurol,2006

4. Migraine preventive drugs differentially affect cortical spreading depression in rat;Bogdanov;Neurobiol Dis,2011

5. A systems neuroscience approach to migraine;Brennan;Neuron,2018

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insights from 25 years of onabotulinumtoxinA in migraine — mechanisms and management;Nature Reviews Neurology;2024-08-19

2. Experience of treatment of chronic migraine with botulinum toxin type A among aesthetic medicine professionals in Poland;Neurologia i Neurochirurgia Polska;2023-08-31

3. Preclinical assessment of onabotulinumtoxinA for the treatment of mild traumatic brain injury-related acute and persistent post-traumatic headache;Cephalalgia;2022-05-11

4. Atogepant – an orally-administered CGRP antagonist – attenuates activation of meningeal nociceptors by CSD;Cephalalgia;2022-03-25